An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer

Cancer Research

Volumn 57, Issue 24, 1997, Pages 5493-5497

  Lavigne, Jackie A ^a   Helzlsouer, Kathy J ^b   Huang, Han Yao ^b   Strickland, Paul T ^b   Bell, Douglas A ^c   Selmin, Ornella ^c   Watson, Mary A ^c   Hoffman, Sandra ^b   Comstock, George W ^b   Yager, James D ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE; ESTRADIOL; GLUTATHIONE TRANSFERASE;

ADULT; AGED; ALLELISM; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; ENZYME ACTIVITY; ESTROGEN METABOLISM; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; METHYLATION; POSTMENOPAUSE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

AGED; ALLELES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CATECHOL O-METHYLTRANSFERASE; DNA; DNA, NEOPLASM; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS;

EID: 15144339383     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Kelsey, J. L., and Gammon, M. D. The epidemiology of breast cancer. CA Cancer J. Clin., 41: 146-165, 1991.
2. Feigelson, H. S., and Henderson, B. E. Estrogens and breast cancer. Carcinogenesis (Lond.), 17: 2279-2284, 1996.
3. Davis, D. L., Bradlow, H. L., Wolff, M., Woodruff, T., Hoel, D. H., and Anton-Culver, H. Medical hypothesis: xenoestrogens as preventable causes of breast cancer. Environ. Health Perspect., 101: 372-377, 1993.
4. Yager, J. D., and Liehr, J. G. Molecular mechanisms of estrogen carcinogenesis. Annu. Rev. Pharmacol. Toxicol., 36: 203-232, 1996.
5. Creveling, C. R. Catechol-O-methyltransferase. Factors relating to the carcinogenic potential of catecholestrogens. Polycyclic Aromatic Cmpds., 6: 253-259, 1994.
6. Tenhunen, J., Salminen, M., Lundstrom, K., Kiviluoto, T., Savolainen, R., and Ulmanen, I. Genomic organization of the human catechol O-methyltransferase gene and its expression from two distinct promoters. Eur. J. Biochem., 223: 1049-1059, 1994.
7. Zhu, B. T., and Liehr, J. G. Quercetin increased the severity of estradiol-induced tumorigenesis in hamster kidney. Toxicol. Appl. Pharmacol., 125: 149-158, 1994.
8. Scanlon, P. D., Raymond, F. A., and Weinshilboum, R. M. Catechol-O-methyltransferase: thermolabile enzyme in erythrocytes of subjects homozygous for allele for low activity. Science (Washington DC), 203: 63-65, 1979.
9. Bertocci, B., Miggiano, V., Da Prada, M., Dembic, Z., Lahm, H-A., and Malherbe, P. Human catechol-O-methyltransferase: cloning and expression of the membrane-associated form. Proc. Natl. Acad. Sci. USA, 88: 1416-1420, 1991.
10. Lundstrom, K., Salminen, M., Jalanko, A., Savolainen, R., and Ulmanen, I. Cloning and characterization of human placental catechol-O-methlytransferase cDNA. DNA Cell Biol., 10: 181-189, 1991.
11. Lachman, H. M., Papolos, D. F., Saito, T., Yu, Y. M., Szumlanski, C. L., and Weinshilboum, R. M. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics, 6: 243-250, 1996.
12. Miller, S. A., Dykes, D. D., and Polesky, H. F. A simple salting out procedure for extracting DNA from nucleated cells. Nucleic Acids Res., 16: 1215, 1988.
13. Maniatis, T., Fritsch, E. F., and Sambrook, J. Molecular Cloning: A Laboratory Manual, pp. 458-126. New York: Cold Spring Harbor Laboratory, 1982.
14. Tait, L., Soule, H. J., and Russo, J. Ultrastructural and immunocytochemical characterization of an immortalized human breast epithelial cell line MCF-10. Cancer Res., 50: 6087-6094, 1990.
15. Berhane, K., Widersten, M., Engstrom, A., Kozarich, J. W., and Mannervik, B. Detoxication of base propenals and other a,b-unsaturated aldehyde products of radical reactions and lipid peroxidation by human glutathione transferases. Proc. Natl. Acad. Sci. USA, 91: 1480-1484, 1994.
16. Ketterer, B. The protective role of glutathione and glutathione transferases in mutagenesis and carcinogenesis. Mutat. Res., 202: 343-361, 1988.
17. Han, X., and Liehr, J. G. Microsome-mediated 8-hydroxylation of guanine bases of DNA by steroid estrogens: correlation of DNA damage by free radicals with metabolic activation to quinones. Carcinogenesis (Lond.), 16: 2571-2574, 1995.
18. Li, Y., Trush, M. A., and Yager, J. D. DNA damage caused by reactive oxygen species originating from a copper-dependent oxidation of the 2-hydroxy catechol of estradiol. Carcinogenesis (Lond.), 15: 1421-1427, 1994.
19. Han, X., and Liehr, J. G. 8-Hydroxylation of guanine bases in kidney and liver DNA of hamsters treated with estradiol: role of free radicals in estrogen-induced carcinogenesis. Cancer Res., 54: 5515-5517, 1994.
20. Wang, M-Y., and Liehr, J. G. Induction by estrogens of lipid peroxidation and lipid peroxide-derived malonaldehyde-DNA adducts in male Syrian hamsters: role of lipid peroxidation in estrogen-induced kidney carcinogenesis. Carcinogenesis (Lond.), 16: 1941-1945, 1995.
21. Stack, D. E., Byun, J., Bross, M. L., Rogan, E. G., and Cavalieri, E. L. Molecular characteristics of catechol estrogen quinones in reactions of deoxyribonucleosides. Chem. Res. Toxicol., 9: 851-859, 1996.
22. Ogawa, T., Higashi, S., Kawarada, Y., and Mizumoto, R. Role of reactive oxygen in synthetic estrogen induction of hepatocellular carcinomas in rats and preventive effects of vitamins. Carcinogenesis (Lond.), 16: 831-836, 1995.
23. Zhu, B. T., Bui, Q. D., Weisz, J., and Liehr, J. D. Conversion of estrone to 2-and 4-hydroxyestrone by hamster kidney and liver microsomes: implications for estrogen-induced carcinogenesis. Endocrinology, 135: 1772-1779, 1994.
24. Weisz, J., Bui, Q. D., Roy, D., and Liehr, J. G. Elevated 4-hydroxylation of estradiol by hamster kidney microsomes: a potential pathway of metabolic activation of estrogens. Endocrinology, 131: 655-661, 1992.
25. Malins, D. C., Holmes, E. H., Polisssar, N. L., and Gunselman, S. J. The etiology of breast cancer. Characteristic alterations in hydroxyl radical-induced DNA base lesions during oncogenesis with potential for evaluating incidence risk. Cancer (Phila.), 17: 3036-3043, 1993.
26. Liehr, J. G., and Ricci, M. J. 4-Hydroxylation of estrogens as marker of human mammary tumors. Proc. Natl. Acad. Sci. USA, 93: 3294-3296, 1996.
27. Taioli, E., Trachman, J., Chen, X., Toniolo, P., and Garte, S. J. A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women. Cancer Res., 55: 3757-3758, 1995.
28. Ambrosone, C. B., Freudenheim, J. L., Graham, S., Marshal, J. R., Vena, J. E., Brasure, J. R., Laughlin, R., Nemoto, T., Michalek, A. M., Harrington, A., Ford, T. D., and Shields, P. G. Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. Cancer Res., 55: 3483-3485, 1995.
29. Feigelson, H. S., Coetzee, G. A., Kolonel, L. N., Ross, R. K., and Henderson, B. E. A polymorphism in the CYP17 gene increases the risk of breast cancer. Cancer Res., 57: 1063-1065, 1997.